Report overview
This report contains market size and forecasts of Sustained Release Ocular Drug Delivery Systems in global, including the following market information:
Global Sustained Release Ocular Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sustained Release Ocular Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Sustained Release Ocular Drug Delivery Systems companies in 2021 (%)
The global Sustained Release Ocular Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposome Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sustained Release Ocular Drug Delivery Systems include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics and GrayBug, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sustained Release Ocular Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sustained Release Ocular Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Global Sustained Release Ocular Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Cataract
Glaucoma
Corneal Transplantation
Others
Global Sustained Release Ocular Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sustained Release Ocular Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sustained Release Ocular Drug Delivery Systems revenues share in global market, 2021 (%)
Key companies Sustained Release Ocular Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Sustained Release Ocular Drug Delivery Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
